Abolish WHAT? A Primer and Resource Guide on Police & Prison Abolition

Disclaimer: This blog post is a resource developed in the spirit of education, conversation, and information sharing. At the time of publication, the Iowa Harm Reduction Coalition has not released a position statement regarding specific policy proposals discussed in this blog.

Over the course of the last few days of May and the first week of June, our communities were forever transformed. Rocked by the deaths of George Floyd, Breonna Taylor, Tony McDade, Jamel Floyd, Ahmed Arbury, and so many more Black lives lost to police brutality, violence, and murder, Black community leaders have organized large-scale direct actions and engaged hundreds of thousands (perhaps millions) of Americans in non-violent protest.

These actions have spurred a national conversation about the fundamental nature of law enforcement. An institution with well known and well documented beginnings as the slave patrol, many Americans are asking the fundamental question: can this institution ever be expected to establish safety for all, when it was never meant to protect Black lives in the first place?


What to do with the police now? Breaking down the dominant narratives in public discourse

The discussion about the nature of police and the institution’s fundamental utility seems to be divided into three factions, each dominated by its own school of thought: In the first, police are viewed to be an essential part of any community, and without police forces, cities would see a substantial rise in violent crime and property crime. This camp views the status quo as largely positive, with the exception of a few bad apples who have severely damaged community-law enforcement trust. They recommend additional training for officers, including education on implicit bias and appropriate use of force, and some members of this camp have voiced support for increased accountability that will help to take the bad apples out of the system before they become the next Derek Chauvin.

The second camp seems to acknowledge that the status quo is not great, and that it’s time to make some changes. This faction sees a role for police in our communities – when presented with abolitionist ideas, individuals whose ideology most aligns with this group may ask, “What will people do if someone breaks into their house with a gun? Who are they supposed to call?” or “What about sexual assault? Won’t that go up if there are no police to deter rapists?” At the same time, team number two does express horror at the murder of George Floyd and the frequency with which Black lives are lost through similar police-involved killings. This group has coalesced around the need to reform the police, and the tactics encompassed by reform are featured in a highly publicized campaign called #8cantwait. Released within several days of Floyd’s murder, #8cantwait has been propped up by the media personality Deray, and local and state-level elected officials are reportedly inundated with requests from their constituents to implement the 8 tactics that make up this particular campaign. Included in this approach are these strategies: ban chokeholds and strangleholds; use of force policies; ban shooting at moving vehicles; require use of force continuum; require comprehensive reporting; require de-escalation; require warning before shooting; exhaust all alternatives before shooting. Some have remarked that they are horrified these strategies are not standard practice across law enforcement agencies.

Individuals from camp three, the abolitionists, have been highly critical of #8cantwait and of Deray. This campaign has been criticized as being, “dangerous and irresponsible for offering a slate of reforms that have already been tried and failed, that mislead a public newly invigorated to the possibilities of police and prison abolition, and that do not reflect the needs of criminalized communities.” Deray and Campaign Zero have also been accused of co-opting the language of abolitionists, and the campaign has applied the term Harm Reduction to a number of its strategies, creating a point of concern for individuals across the country whose work is entrenched an understanding of Harm Reduction as something much, much more transformative than political pragmatism and change that is incremental or merely symbolic. In reviewing the Campaign Zero website, a new graphic has debuted that heavily relies on harm reduction and abolition, but provides little context about these concepts and attributes no new tactics to these philosophies.

Read: #8cantwait

What a time to be alive

The abolitionists make up the final thought faction, and their interpretation of the solutions needed in this moment can perhaps be summarized as a counterpoint or response to the second group: The 8cantwait campaign promises to reduce police killings by 72%. At what point will we say that enough is enough? At what point will another loss of Black life be completely unacceptable? So unacceptable that in order to keep our commitment to protecting life, we are willing to invest in changes that are bold and disruptive. The abolitionists recognize that the terminology used to describe their theoretical approach is full of drama and can lead to confusion and fear, but when simplified, is not a unique phenomenon: if the current system of policing does not work, the funding that supports this system may be better allocated elsewhere. Public dollars invested in building support and providing care for Black communities can help to improve health, wellbeing, connectivity, and economic security. A byproduct of such an investment is a drop in crime. In the meantime, many community needs that are handled by police departments can be re-assigned and shifted elsewhere, particularly to community-based institutions that do not have a history that is as intimately tied to slavery and racism. The operative idea here is that policing is not working. In his seminal book, The End of Policing, scholar Alex Vitale writes,

“The problem is not police training, police diversity, or police methods. The problem is the dramatic and unprecedented expansion and intensity of policing in the last forty years, a fundamental shift in the role of police in society. The problem is policing itself.”

In this case, we are left with no other choice but to look to other institutions and professionals to fulfill the needs of the community. In response to the #8cantwait campaign, a group of thought leaders from this camp created an alternative campaign, #8toabolition. The strategies named in this campaign can be read in their entirety on the campaign’s website.

Understanding Abolition’s Goals: Resources for Learning

In the past two weeks, the overton window has been shifted to an extent that no one would have probably believed to be possible. And as many Americans encounter ideas about police reform and abolition for the first time, it is crucial to remember that these are not new ideas. Abolitionist thought has origins in the scholarship of Black feminist theorists, and leaders of this movement have invested many decades into the belief that a better world is possible.

I am writing about the divisions in the public discourse on policing not because it represents a particular area of expertise for me, but because this is fundamentally a conversation about the concepts of freedom, autonomy, care, support, and justice. It is a conversation about what it means to live in relationship with other human beings – and what commitments we are willing to make to one another. These concepts also lie at the heart of public discourse surrounding drug use, and they create a tie between the Harm Reduction movement and movements that seek to build a stronger apparatus for the provision of safety. Primarily, I am writing about this because of the terrific amount of confusion that exists with regards to the concept of abolition, and its contextual relationships with 8cantwait and police reforms. This is intended to serve as a highly simplistic summary of the differences between reformists and abolitionists, and, most importantly, provide access to information and resources for learning and education. Below I have listed several essential resources, which I am using in order to improve my own knowledge and understanding. IHRC has fostered critical conversations since 2016 – conversations that aim to be honest, real, and open to all. If you’d like to join an active conversation about abolition, you may wish to head over to our instagram account and let us know your thoughts on abolition, reform, and more.

The only resource you’ll ever need: an extraordinarily comprehensive guide to learning about prisons, police, and punishment.

Alex Vitale is a Professor of Sociology at Brooklyn College in New York. His 2017 book, The End of Policing, reveals the origins of modern policing as a tool of social control and documents the expansion of police authority. Taking a global perspective, Vitale reviews the many varied forms of policing and explores the alternative systems that communities around the world have created in order to respond to homelessness, sex work, drug use, gang violence, undocumented border crossings, mass shootings, school-based violence, and more.

Vitale’s book is currently available for free in PDF form from the publisher.

For those who aren’t able to invest in reading a full book on the topic, Vitale has given many interviews and published many op-eds in recent weeks:

Much of the thinking about how communities should respond to this moment lies in the writings of two women and one of their students.

  • Angela Davis, the famous activist and scholar, writes about an adjacent but relevant institution in her book, “Are Prisons Obsolete?”
  • Ruth Wilson Gilmore is a close friend of Davis’ and a slightly less famous contemporary. Her work is profiled in an excellent New York Times Magazine article from 2019
  • Finally, Michelle Alexander is a student of Davis and Gilmore, and her now classic book, The New Jim Crow, is a legal history that gives context to the current questions before us regarding what to do with police, prisons, and more.


IHRC welcomes your thoughts and feedback on the concepts presented in these writings at any time. Please get in touch at hello@iowaharmreductioncoalition.org.


Police Violence & Anti-Black Racism: A Statement from the Iowa Harm Reduction Coalition

Black lives matter.

An opinion. A radical political ideology. An example of “reverse racism.” The name of a terrorist organization. For far too many people, these three simple words are capable of invoking responses ranging from indifference to outright hostility. And yet, from the beginning, the words Black Lives Matter have meant simply this: the lives of Black people have value and meaning.


From the killing of George Floyd in Minnesota, Tony McDade in Florida, Breonna Taylor in Louisville and Ahmaud Arbery in Georgia, recent events have spurred protest and catalyzed a national conversation about anti-Black racism. While these four deaths are some of the most recent and the most public, they are certainly not the only killings which Black communities are grieving and responding to in this moment. After reading a letter written by the President of Emerson College, I wondered if the 8 minutes that it took for a police officer to kill George Floyd just exceed the number of minutes that make up a person’s “lifetime bandwidth” to witness and experience dehumanization, brutalization, and injustice perpetrated by white people. 8 minutes is just enough time to review a mental film reel of lynchings, murders, and Black death: Trayvon Martin. Michael Brown. Emmett Till. Sandra Bland. Freddie Gray. Tamir Rice. Eric Garner. Whatever “storage space” that must exist within a collective group of human beings to hold trauma and grief appears to, finally, be full. The anguish reflected in the events of past weeks suggests that for Black Americans, enough is enough. No capacity remains to process another loss of Black life. These aforementioned events also remind us of the lengths that white people will go to in order to protect the social order in which we experience dominance. It is abundantly clear that we have chosen to prioritize our own comfort, protection, and ease over a fundamental respect for Black life.

The violence perpetrated by law enforcement officers in past weeks is alarming. The arrests of journalists along with the brutal assaults on crowds peacefully demonstrating or individuals simply going about their daily lives, is an expression of the polices’ desire to maintain dominance and white supremacy. But it is not necessarily a new phenomenon. Policing is an institution with its roots in anti-Black racism. It is well known that America’s initial police forces were slave catchers, and these militias evolved into a profession that serves as the protectorate for the wealth and property of white people. While today the police are charged with protecting the safety of all individuals in a community, it is reasonable that an institution with its roots in such a history may not necessarily be one without bias, or that is capable of fulfilling this charge.

The statements in the paragraph above have long been viewed as “too dangerous” or “too fringe” for organizations to endorse, especially in Iowa. But a willingness to speak truthfully about the vestiges of slavery, and their impacts today, is reflected in recent statements from the nation’s leading health care and public health organizations: In a statement released last week by the American Medical Association (AMA), titled, “Police brutality must stop,” the most influential entity representing physicians in the U.S. recognized that while many who serve in law enforcement are committed to justice, police violence is a striking reflection of the American legacy of racism. The AMA outlined a growing body of medical research that documents the significant race-based disparity in experiences with police violence and noted that such experiences are linked to adverse chronic health outcomes for all Black people. Police violence results in higher levels of chronic stress among Black Americans, which manifests in worse mental health outcomes and is embodied through shorter life expectancies. This tells us that policing is simply not an institution that can create or ensure safety for Black communities.

At the same time, it is necessary that I recognize the humility and thoughtful leadership that are demonstrated in statements from Iowa’s law enforcement community on the killing of George Floyd. In particular, statements from the Iowa Police Chiefs Association and from Sgt. Brad Kunkel (the winner of yesterday’s Democratic primary election for Sheriff in Johnson County) model a preference for de-escalation and a willingness to engage in dialogue, even when it is uncomfortable. There are highly varied relationships between community members and their law enforcement institutions across the state. The vast majority of individuals who work in Iowa’s law enforcement professions do so because of a commitment to the belief that our world can be transformed into one that establishes safety for all. While we may at times disagree on the specific tactics or policies that are necessary or effective, I believe that all of our work can ultimately be united in the desire to create communities where everyone can experience peace, freedom, and joy. For this reason, IHRC is committed to building relationships with all community members and leaders, including individuals employed by law enforcement agencies, across our state. Since 2016, we have maintained a desire and willingness to engage in conversations with law enforcement that allow everyone to be fully seen.


As communities examine the role of racism in the justice system and beyond, the Iowa Harm Reduction Coalition is responding to these events and the resultant calls to action from Black leaders. We, in turn, call on our elected leaders to publicly and deliberately engage with the requests for structural change, divestment in law enforcement institutions, and investment in safety, wellbeing, and healing for Black communities.

The purpose of this statement and call to action is three-fold:

First

To offer the briefest of responses to those Black folks who we live and work alongside and who are our colleagues, clients, patients, acquaintances, dear friends, service providers, neighbors, strangers, mentors, writers, friends’ babies, elected officials, celebrities, teachers, lovers, healers, sisters, brothers, children: you are heard. Both in your expressions of anguish and insistence that real, lasting, structural change happen, and that it happens not in a month or in a year, but now.

Second

To offer a statement that is primarily directed towards white people (particularly and especially those living in Iowa) that articulates Harm Reduction’s ideological relationship with racial justice and anti-racism work; highlights, in Floyd’s killing, the invocation of a process of dehumanization that is deeply intertwined in policies that criminalize drugs; and invites engagement, partnership, and accountability in IHRC’s work.

As a young organization, we are committed to receiving and responding to feedback as it concerns the themes discussed above and in the coda that follows. Perhaps most importantly, we understand that as an organization that is founded and led by white people, just as much of the work to be done concerns our own processes, strategies, and operations, which we will continue to share information about publicly. We affirm the idea that anti-racism is not a destination, and that as white people we will never become un-racist. A few days or weeks of training and reading may facilitate personal growth, but does not undo a culture that has been built over the course of many centuries. As such, we are engaged in a constant process of conversation, learning, and growth, and I fully expect that our attempts at ally-ship will at times be imperfect and at others potentially ill-informed. It is for this reason that I welcome the opportunity to receive feedback, and invite you to share your thoughts. And whether that be in a week or in two years, the prioritization of accountability is sincere

Third

To urge local leadership to consider the aforementioned statements from the American Medical Association, the Drug Policy Alliance, the American Public Health Association, and the specific calls to action from those leaders who affirm that Black Lives do Matter and entertain this question: Can our community guarantee: not one more loss of Black life at the hands of police? In responding to this question, it is critical that elected leaders steer away from the allure of reforming the current system through tactics that are well known to be ineffective, like implicit bias trainings, early warning systems for poor conduct, or civilian review boards. While none of these tools are inherently evil, the current moment makes clear that an institution cannot be reformed if it was never meant to protect Black lives in the first place.

During the month of June, IHRC will be sharing a number of updates, events, and projects that connect to the topics and themes in this statement. While the majority are previously planned and part of our ongoing work that relates to criminal justice reform, drug policy advocacy, and the provision of drug user health services across a number of Iowa communities, several initiatives are planned as part of our internal and external response to the events that have occured in the past week.

To echo the sentiments conveyed above, I invite you to contact me at sarah@iowaharmreductioncoalition.org at any time. Please feel free to reach out with your questions, thoughts, or concerns.

Sincerely,

Sarah Ziegenhorn
Founding Executive Director
Iowa Harm Reduction Coalition

Coda: A Deeper Dive

At the Intersection: Harm Reduction & Racial Justice

In the events leading up to the killing of George Floyd and in the public conversation held in the aftermath of his death, drug use has played an often subtle but critical role. This comes as no surprise, given the way in which drug use is meant to establish deviance and indicate poor moral character. As Floyd was held to the ground by Minneapolis Police Officer Derek Chauvin, another police officer looks on and states to a crowd of youth who were gathered nearby, watching and filming the encounter, “This is why you don’t do drugs, kids.”  Earlier in the encounter, another officer and Chauvin discuss “excited delirium,”a term that is not recognized in medicine and has been historically used in law enforcement settings to describe alterations in consciousness and mental status attributable to poly-drug use, as well as establish a cause for sudden death while in police custody. The term is controversial and many in medicine believe that it is used as biological justification for deaths among Black men that result from police violence.  In the criminal complaint associated with his death, a press release summarizing a forensic report asserts the idea that his death may not have been the result of police force, but rather by drug use: “The combined effects of Mr. Floyd being restrained by the police, his underlying health conditions and any potential intoxicants in his system likely contributed to his death.” In the results from an autopsy ordered by Floyd’s family, released today, Floyd’s cause of death is listed as asphyxiation due to compression of nerves in his back and neck.  In all of these moments, we are led to believe that George Floyd’s death is a reasonable or expected outcome for someone who may possess or use drugs. Kassandra Frederique, the incoming Executive Director of the Drug Policy Alliance summarizes the meaning of these references to drug use:

“With George Floyd most recently, Breonna Taylor earlier this month, and countless others before them, perceived drug possession and drug use served as a justification by law enforcement to dehumanize, strip dignity from, and ultimately kill people of color.”

In a statement from the Drug Policy Alliance, released late last week, Kassandra Frederique states why the work to reform drug policy is fundamentally linked with the work for racial justice:

“Drug involvement–whether perceived or real–has provided a convenient excuse for these violent and too often fatal law enforcement interactions. [We must] continue fighting to remove drug involvement as a cover for disregarding the dignity and sanctity of human life. And we will challenge and hold these institutions accountable. We refuse to stand by while another person cries out, as Eric Garner and George Floyd did, “I can’t breathe,” as law enforcement ends their life.

Ending the failed war on drugs will not legalize Black people, but it will disrupt a system that chips away daily at the very core of our humanity. We don’t need symbolic gestures, we need to strategize, organize, and build campaigns to ensure this doesn’t happen again. We stand ready to work with our allies to do our part.”

The War on Drugs & George Floyd Collide

Harm Reduction is an ideological approach to drug use that views the expertise gained through lived experience as paramount. Harm Reduction prioritizes the voices, knowledge, and wisdom of people with lived experience and understands that in order to create communities that are healthy, safe, and whole, the people who are directly impacted must be centered and intimately involved in decision making, policy development, and program implementation. With regards to substance use, we understand that people who use drugs (PWUD) expect to be engaged in the creation of any policy or program that is meant to serve or improve the lives of PWUD. Thus, we recognize the fundamental importance of centering the voices and expertise of Black people in decision-making (of any kind and at all levels) that concerns the conditions in which Black Americans live, including but not limited to racism and the legacy of slavery as an institution.

Harm Reduction is also a social movement and community of people working for justice, dignity, freedom, and respect for the people who use illicit, psychoactive drugs. We know that the lives of PWUD are deeply impacted by the laws under which these drugs are regulated, and that the origins of these regulations are deeply intertwined with late 19th century / early 20th century ideologies regarding race and power. Simply put, many of the race-based disparities that exist today in overdose deaths, HIV rates, arrests, sentencing lengths, and recidivism rates are the outcome of a legal framework that has assigned meaning to classes of drugs by connecting their use with racial and ethnic identity as a means of establishing and perpetuating deviance. The state has carefully cultivated the propaganda that drug use begets deviance, violence, and disorder thus begets a system in which those people who use drugs must be regulated, policed, and controlled in order to reduce violence, deviance, and disorder for the broader collective to be guaranteed safety.

Here is a fundamentally important point: While there are obvious parallels between the struggles and institutional hostility faced by PWUD and BIPOC, we are in no way claiming equivalency between the two, only highlighting that the similarities provide motivation and strengthen our desire to work to dismantle the legacy of white supremacy and entrenched racism.


Harm Reductionists recognize that our day to day work is often technical and focused on minimizing risks for adverse health outcomes at multiple scales, from training individuals to administer a medication that may save their life in the event of overdose, to debating the minutiae of the language in a bill that proposes minor revisions to the Iowa code. Yet we also know that this work is also deeply symbolic. Our sustained commitment is reflective of the belief in a much larger vision for what our communities could one day look like. This work is thus done in service to the idea that a world is possible where institutions and individuals engage with one another through relationships of support, healing, joy, and care, rather than punishment, authority, shame, or violence. In other words, it is to say that we fundamentally connect our work to racial justice, and know that to transform the way our world engages with drugs and the people who use them also means to transform the way we engage with Black lives and value assigned to them.

Learn more about IHRC's six policy priorities for 2020

IHRC May 2020 Volunteer of the Month: Spotlight on Mitchell Hooyer

Since 2016, IHRC has trained over 500 volunteers from across Iowa to become harm reduction advocates and direct service providers. Maintaining nearly 100 active volunteers in our program at any one time, the individuals who dedicate their time, energy, thoughtfulness, and talents to IHRC give the organization its strength and staying power. Volunteers provide support at nearly every level of IHRC's program, from late night naloxone deliveries for clients to trips across the state to meet with legislators in their homes. Each month, the IHRC community recognizes one individual for their commitment to advancing drug user health in Iowa. Through the "Volunteer of the Month" Award, our community honors the contributions and impact a particular individual has made. While this award has been given since 2017, as of mid-2020 we're taking the recognition public and sharing our monthly awardee with the wider audience engaged with our work. Each winner is recognized with either a gift from IHRC's merch shop or a Harm Reduction book of their choosing. Please join us in celebrating the contributions these individuals make to our communities, and the entire state of Iowa, each day.

Mitchell Hooyer


Mitchell is a medical student at the University of Iowa Carver College of Medicine with one year left before entering an Emergency Medicine residency. He’s a native Iowan who grew up on a cattle farm in Northwest Iowa and went to college at Drake University in Des Moines where he majored in Biology and Bartending. Mitchell has been with IHRC since 2018, volunteering in a variety of positions including street outreach, operating the Central Iowa hotline and delivery service, working the Cedar Rapids front desk, planning webinars, and most recently starting a student harm reduction interest group at the University of Iowa. Outside of IHRC and school he enjoys reading (check out IHRC’s forthcoming blog post for recommendations), playing volleyball, and buying too many new plants.

Mitchell has been a volunteer with IHRC since beginning medical school in Iowa City and applied to volunteer in January 2018, training that spring. Over the past 2.5 years, Mitchell has become one of our program’s key team members. While living in Des Moines from January – December 2019, Mitchell worked closely with Deborah (IHRC’s Central Iowa Program Manager) and took care of the hotline + client deliveries on a weekly basis. He also has become immersed in the broader harm reduction field and has a clear passion for the individuals we work with & the community we serve. This passion is made visible by the curiosity he brings to this work; his commitment to learning; a consistent engagement with new resources and materials; and the way in which his knowledge-base seems to grow exponentially with regards to: a) client experiences, goals, challenges, and needs; b) the inner-workings of health, social, and criminal-legal systems and how these systems impact people via the production of structural forces; c) research publications, thought leaders, critical organizations, and experts in the field; and d) traditional news media content, books, social media content, and more. Mitchell returned to Iowa City in January and has spent the last two months running the front desk in the office on Monday and Wednesday afternoons. While the office has been unusually quiet due to COVID-19, Mitchell has also used his time to develop a number of other projects. Recognizing the need for new initiatives, organizations, and structures that can approach harm reduction work from different perspectives, Mitchell has put together the Harm Reduction Interest Group for Medical Students, which will liaise with the national group of a similar name. This group will be able to expand opportunities for training and education in drug user health for all medical students. Mitchell has developed a structure for the group that is highly strategic, uniquely well organized, and sets the group up for success in the short, medium, and long term future. Mitchell is currently working on a number of other projects within IHRC, including the summit and the COVID-19 research project. As a grassroots organization whose strength comes directly from the leadership and engagement of all participants within the group, IHRC is significantly better off because of Mitchell’s commitment to the work we do, and because of the enjoyment and meaning that he derives from it and brings to it. Thanks so much Mitchell, for all of the work you have put in over the past two years, and for all of the good things you have planned for the next year!


Nation’s Leading Drug Policy Experts Demand Medication Assisted Treatment and COVID-19: Treatment Reforms

During the COVID-19 pandemic, it is critical to remember that we are still in the midst of an overdose crisis.

While many regulators have argued that methadone and buprenorphine policies must be deliberately restrictive due to the risk of overdose, adverse medication effects, and medication diversion, the COVID-19 crisis has forced many regulating bodies to re-evaluate these policies in order to comply with the urgent need for communities to practice social distancing and sheltering-in-place. Multiple government agencies including SAMHSA, the DEA, Medicare, and Medicaid have recently announced policy changes to allow for more flexible prescribing and dispensing. While these changes are a step forward, clinics have been either reluctant or resistant to fully implement them to the extent allowable under law. In light of the evolving pandemic and the needs of the community, we must not allow fears of overmedication and diversion to outweigh the health risks caused by patients being forced daily to congregate in large groups, or being driven to an adulterated illicit drug supply.

Close person-to-person contact and group assembly are currently actions deemed hazardous to public health. Unfortunately, “sheltering in place” is unrealistic for many people who use drugs. People who use opioids are either forced to continue to engage with the illicit drug market or must comply with prohibitive and insurmountable requirements to receive medications for Opioid Use Disorder (OUD). Many opioid users are at an increased risk of COVID-19 infection due to being immunocompromised and/or having comorbid health conditions.

In order to reduce the risk of COVID-19 infection, involuntary withdrawal, and drug poisoning, the Urban Survivors Union and the undersigned organizations strongly recommend the following measures be taken immediately:

1) The only acceptable standard for discharge of patients from OUD treatment during the COVID-19 outbreak shall be violent behavior that would endanger their own health and safety or that of other patients or staff.

2) Administrative detox shall be fully suspended during the pandemic and patients shall be provided the opportunity to request dose increases as needed, given that the illicit drug market will continue to experience fluctuations and patients need access to these life-saving medications. Patient doses shall not be reduced during the transition to take-home care unless they request adjustments to their doses, or documented medical emergencies require it and patients cannot consent due to medical crises, as may be the case with severe respiratory distress resulting from COVID-19 infection.

3) Referrals for COVID-19 testing shall be made available at all opioid treatment programs (OTPs), as well as syringe service programs. Staff shall receive training to recognize the symptoms of COVID-19 and be familiarized with protocols to refer patients for further testing. Harm reduction providers can also play an essential role in “flattening the curve” of transmission by identifying cases, making medical attention available to those who test positive, and teaching life-saving harm reduction skills to help people stay safe during this crisis. Plain language and evidence-based public health materials about COVID-19 prevention, symptom identification, and treatment should be available in locally prominent languages at all locations for participants and their communities.

4) During the COVID-19 national emergency, healthcare professionals–including doctors, nurse practitioners, physician assistants, and pharmacists–shall not be required to complete the previouslymandated training and waiver to prescribe these medications, thereby making MAT available in all settings. Prescribers shall not have limitations on the number of patients that they can treat. Naloxone and other overdose prevention tools (i.e. fentanyl test strips) shall be prescribed or made available with all dispensed medications in compliance with state law.

5) Opioid treatment programs (OTPs), prescribing clinicians, and pharmacies shall actively work to expand access to methadone treatment through the medical maintenance/office-based and pharmacy-delivery methods currently allowed by federal exception/waiver. The existing OTP regulations for the dispensing of MAT shall be temporarily adjusted to require all pharmacies to dispense these medications. This will reduce the risks of transmission associated with daily clinic attendance and person-to-person contact. In accordance with SAMHSA recommendations, lockbox requirements for take-home dispensing shall be suspended. Standard dispensing protocols for other opioid medications are deemed sufficient, since child- and tamper-proof bottles are already in use for methadone and buprenorphine. (Per SAMHSA’s TIP 43, Chapter 5: “Some programs require www.ncurbansurvivorunion.org 3 patients to bring a locked container to the OTP when they pick up their take-home medication to hold it while in transit. This policy should be considered carefully because most such containers are large and visible, which might serve more to advertise that a patient is carrying medication than to promote safety.”)

6) Take-home exception privileges shall be expanded to the maximum extent possible, limited only by available supply and operations for delivery. Any bottle checks that clinics wish to conduct shall be conducted by tele-medicine. Take-home schedules shall be authorized for individuals in all medical settings, including pharmacies and mobile vans. In light of new SAMHSA guidelines, clinics shall allow 14 to 28 days of take-home privileges to as many patients as possible. Patients testing positive for benzodiazepine or alcohol use shall be allowed the take-home privileges outlined in SAMHSA guidelines, but may be additionally required to check in via telemedicine for the purpose of decreasing the risk of adverse reactions, including overdose. Access to take-home doses is critical to keep patients engaged and retained in treatment.

7) Telehealth and service by phone shall replace any and all in-person requirements and appointments as the primary means of service provision until social distancing guidelines change. Toxicology requirements shall be suspended for the duration of telehealth-based services. Telemedicine services shall include waivered platforms, such as telephone intakes and video conferencing, as some patients may have different access needs.

8) The regulatory in-person requirements for methadone inductions shall be lifted in order to be consistent with the new policy changes for buprenorphine inductions. Clinic-based in-person appointments shall conform to social distancing requirements and OSHA guidelines for the management of the COVID-19 pandemic.

9) DEA restrictions on mobile medication units shall be revised to accommodate delivery of medications to individuals who are sequestered in their homes, are quarantined, or live in rural communities that are 15 miles or more from the nearest opioid treatment program.

10) State and federal Medicaid dollars shall be expanded to cover all costs for take-home medications not otherwise covered by insurance for patients experiencing financial hardship due to COVID-19. In states that did not expand Medicaid, the state shall be the payor of last resort.

In the interest of saving lives and adhering to existing public health protocol for management of COVID-19 transmission, it is necessary to make significant revisions to existing regulatory standards. This is a critical time to take decisive action for the protection of patients, providers, their families, and the community. As our healthcare system reaches full capacity and becomes overburdened by COVID-19-related emergencies, as seen in Italy and Spain, providers on the front lines will be forced www.ncurbansurvivorunion.org 4 to make life and death choices. These recommendations outline a plan of primary prevention that will minimize the burden on our healthcare system and save lives during this national emergency.

We, the undersigned, are a coalition of direct service providers, community advocates, public health officials, medical professionals, human rights groups, people in recovery, treatment professionals, members of impacted communities, and many others. We ask SAMHSA, the DEA, and all other federal, state, and local regulatory bodies and health authorities to adopt these recommendations fully and immediately in light of the COVID-19 pandemic.

Organizations

Urban Survivors Union
Louise Vincent, MPH
Executive Director

National Harm Reduction Coalition
Monique Tula
Executive Director

The National Alliance for Medication-Assisted Recovery
Zachary Talbott, MSW
President
Joycelyn S. Woods, MA
Executive Director

Faces and Voices of Recovery
Patty McCarthy, M.S.
Chief Executive Officer

National Viral Hepatitis Roundtable
Lauren Canary, MPH
Director

Law Enforcement Action Partnership
Major Neill Franklin (Ret.)
Executive Director

The Levenson Foundation
Benjamin A. Levenson
Chairman

Foundation for Recovery
Dona M. Dmitrovic, MHS
Executive Director

National Council for Behavioral Health
Chuck Ingoglia
President and CEO

305 Psychotherapy Group
Mark Houston, LCSW
Owner and Psychotherapist

Addiction Professionals of North Carolina
Sarah Potter, MPA
Executive Director

AIDS United
Drew Gibson, MSW
Policy Manager for HIV & Drug User Health

Alcohol & Drug Abuse Certification Board of Georgia
Amanda Finley
Executive Director

Alliance for Positive Health
Diana Aguglia
Regional Director

The BALM Training Institute for Family Recovery Services/Family Recovery Resources
Beverly A Buncher, MA, CBFRLC, PCC
Chief Executive Officer

Bay Area Workers Support
Maxine Holloway, MPH
Co-Founder

Benevolence Farm
Kristen Powers
Interim Executive Director

Better Life in Recovery/Springfield Recovery Community Center
David Stoecker, LCSW
Executive Director

BioMed Behavioral Healthcare, Inc
Brian A McCarroll DO. MS. ABAM
CEO, President

Choices Recovery Trainings
Ginger Ross, CRSW, NCPRSS
Owner/Trainer

Church of Safe Injection
Kari Morissette
Director

Circle for Justice Innovations
Aleah Bacqui Vaughn
Executive Director

City of Revere – Substance Use Disorder Initiatives Office
Julia Newhall, BSW, CPS
Director

Coastal Holistic Care
Jessi Ross
Founder

Connecticut Certification Board
Jeff Quamme, MSW
Executive Director

DanceSafe
Mitchell Gomez
Executive Director

Desiree Alliance
Cristine Sardina, BWS, MSJ
Director

društvo AREAL
Janko Belin
President

ekiM For Change
Diannee Carden Glenn
Director

Grayken Center for Addiction, Boston Medical Center
Michael Botticelli, MEd
Executive Director

Greater Hartford Harm Reduction Coalition Inc.
Mark A. Jenkins
Executive Director

Guilford County Solution to the Opioid Problem
Chase Holleman, LCSW, LCAS
Program Director

Harm Reduction Action Center
Lisa Raville
Executive Director

Harm Reduction Ohio
Dennis Cauchon
President

Harm Reduction Therapy Center
Jeannie Little, LCSW
Executive Director

Health in Justice Action Lab
Leo Beletsky, JD MPH
Director

Health Professionals in Recovery
William C. Kinkle, RN, EMT-P, CRS
Co-Owner

Health Services Center, Inc.
Melissa Parker
Prevention Projects Director

Healthy Streets / Health Innovations
Mary Wheeler
Program Manager

Iowa Harm Reduction Coalition
Sarah Ziegenhorn
Executive Director

Katal Center for Health, Equity, and Justice
Gabriel Sayegh, MPH
Co-Executive Director

The Lemire Group LLC
Dean Lemire
Owner

Lifespan Counseling
Dene Berman, Ph.D., MPH, ABPP, MAC
Director

Lysistrata Mutual Care and Collective Fund
Cora Colt
Co-Founder and Treasurer

MEDPEARL LLC
Deanna Dunn, PharmD
Owner/Pharmacist

The Middle East and North African Network of/for People who use Drugs
Hasan Taraif
Executive Director

Minnesota Recovery Connection
Wendy Jones
Executive Director

Movement for Family Power
Lisa Sangoi and Erin Coud
Co-Founders and Co-Directors

NCADD- NJ
Heather Ogden, CPRS, CRSP, CADC Intern
Advocacy Coordinator

Northern Berkshire EMS
Stephen Murray, BBA, NRP
Paramedic Supervisor

ONESTOP Harm Reduction Center, North Shore Health Project
Mary Doneski, MA
Program Manager

PeerNUPS/Athens/Greece
Christos Anastasiou
Coordinator

Pennsylvania Alliance of Recovery Residences
Fred Way, MA
Executive Director

Pennsylvania Harm Reduction Coalition
Devin Reaves, MSW
Executive Director

People’s Action
Sondra Youdelman
Campaigns Director

The People’s Harm Reduction Alliance
Shilo Jama
Executive Director

The Perfectly Flawed Foundation
Luke Tomsha
Executive Director

Philadelphia Drug Users Union
David Tomlinson, BA
Founder

Sex Workers Organizing Project- USA
Christa Daring
Executive Director

The Southern Tier AIDS Program
John Barry, LMSW
Executive Director

Students for Sensible Drug Policy
Betty Aldrich
Executive Director

Students For Sensible Drug Policy Africa
Ewelle Sylvester Williams, SW
Vice Chairman
Substance Use, Policy, Education and Recovery

PAC
Haley McKee
Co-Chair

Suncoast Harm Reduction Project
Julia Negron, CAS
Founder and Lead Organizer

Tennessee Recovery Alliance
Sara Alese
Executive Director

Texas Drug User Health Alliance
Mark Kinzly
Executive Director

Texas Harm Reduction Alliance
Joy Rucker
Executive Director

Voices of Community Activists and Leaders New York
Jeremy Saunders
Executive Director

Whose Corner is it Anyway
Caty Simon
Founding Co-Organizer

Women With A Vision
Christine Breland Lobre, MHS, MPH, LPC
Program Director

Zanzibar Network of People Who Use Drugs
Kassim Nyuni
Executive Director

Drug Policy Alliance
Kassandra Frederique
Managing Director, Policy Advocacy &
Campaigns

International Certification & Reciprocity
Consortium
Crystal Smalldon, CCAC, CIAC, RSSW
President

Behavioral Health Association of Providers
Pete Nielsen, MA, LAADC
CEO

Center on Addiction / Partnership for DrugFree Kids
Frederick Muench, Ph.D.
President

National Advocates for Pregnant Women
Lynn M. Paltrow, J.D.
Founder and Executive Director

Recovery Advocacy Project
Ryan Hampton
Organizing Director

Open Society Foundations
Sarah Evans
Unit Manager, Public Health Program
Kasia Malinowska-Sempruch
Director, Global Drug Policy Program

Brave Technology Coop
Gordon Casey
Chief Executive Officer

Broken No More
Tamara Olt, M.D.
Executive Director

CADA of Northwest Louisiana
Bill Rose, LAC, CCS, CCGC
Executive Director

C4 Recovery Foundation, Inc.
Ricard Ohrstrom, Chairman
Jack O’Donnell, CEO

Center for Optimal Living
Andrew Tatarsky, Ph.D.
Executive Director

Center for Popular Democracy/ Opioid Network
Jennifer Flynn Walker
Senior Director of Advocacy and Mobilization

Central Texas Harm Reduction
Richard Bradshaw
Community Outreach Leader

CheckUpandChoices.com
Reid K Hester, Ph.D.
Director, Research Division

Chicago Drug Users Union
Peter Moinichen, CADC, CODP, MAATP
Co-Founder

Chicago Recovery Alliance
Brandie Wilson
Executive Director

Exponents, Inc.
Joseph Turner, J.D.
President and CEO

Faith In Public Life
Blyth Barnow, MDiv
Harm Reduction Faith Manager

Families for Sensible Drug Policy
Carol Katz-Beyer
President

Florida Opiate Coalition- Block by Block
Bonny Batchelor
Director

Foundation for Recovery
Dona M. Dmitrovic, MHS
Executive Director

Full Circle Recovery Center, LLC
Stephanie Almeida, CDAC
Founder

Georgia Overdose Prevention
Laurie Fuggitt, RN and Robin Elliott, RN
Co-Founder

GoodWorks: North Alabama Harm Reduction
Morgan Farrington
Founder

The Grand Rapids Red Project
Stephen Alsum
Executive Director

HIPS
Tamika Spellman
Policy and Advocacy Associate

HIV/HCV Resource Center
Laura Byrne, MA
Executive Director

Hope Recovery Resources
Beth Fisher Sanders, LCSW, LCAS, MAC, CCS, MATS
Chief Executive Officer

HRH413
Albert Park, MSW
Co-Founder

International Network of People Who Use Drugs
Judy Chang
Executive Director

Illinois Association of Behavioral Health
Sara Howe, MDA
Executive Director

Inclusion Recovery
Dan Ronken, LPC, LAC
Founder

Indiana Recovery Alliance
Kass Botts
Executive Director

Innovative Health Systems
Ross Fishman, Ph.D.
President

Instituto RIA
Zara Snapp
Co-Founder

New England Users Union
Jess Tilley
Executive Director

New Jersey Harm Reduction Coalition
Jenna Mellor
Executive Director

A New PATH, Parents for Addiction Treatment & Healing
Gretchen Burns Bergman
Executive Director

New View Addiction Recovery Educational Center
Jennifer A. Burns, MA
Executive Director

New York Center for Living
Audrey Freshman, Ph.D., LCSW, CASAC
Executive Director/Chief Clinical Officer

New York State Harm Reduction Association
Joseph Turner, J.D.
Co-Chairperson

North American Syringe Exchange Network/Tacoma Needle Exchange
Paul A. LaKosky, Ph.D.
Executive Director

North Carolina Harm Reduction
Shelisa Howard-Martinez
Executive Director

North Carolina Survivors Union
Louise Vincent, MPH
Executive Director

Project Point Pittsburgh
Alice Bell, LCSW
Overdose Prevention Project Coordinator

Protect Families First
Annajane Yolken
Executive Director

Provenance Counseling
Lisa S Musarra, MSW, LCSW, LCADC, ICADV
Owner

The Reach Project, Inc and Reach Medical, PLLC
Justine Waldman, MD, FACEP
Chief Executive Officer

Reframe Health and Justice
Sasanka Jinadasa
Partner

Rights & Democracy NH, Rights & Democracy VT, Rights & Democracy Institute
Kate Logan, MA/ABD
Director of Programming & Policy

R Street Institute
Carrie Wade, Ph.D., MPH
Director of Harm Reduction Policy
Chelsea Boyd, MS
Research Associate Harm Reduction Policy

San Francisco AIDS Foundation
Laura Thomas, MPH, MPP
Director of Harm Reduction Policy

The Seven Challenges LLC
Robert Schwebel, Ph.D.
Author and Program Developer

Sex Worker Advocacy Coalition
Tamika Spellman
Lead Organizer

Sex Workers Outreach Project Behind Bars
Jill McCracken, Ph.D.
Co-Director

Texas Harm Reduction Conference
Emily Gray
Co-Founder

Texas Overdose Naloxone Initiative
Mark Kinzly
Executive Director

Truth Pharm
Alexis Pleus
Executive Director

Ukrainian Network of People who Use Drugs
Anton Basenko, ME
Chair of the Board

University of Missouri, St. Louis Missouri Institute of Mental Health
Claire Wood, Ph.D.
Rachel Winograd, Ph.D.
Addiction Science Faculty

Urban Survivors Union, Greensboro Chapter
Derek McCray Miller
Member
Dr. Vando Medical Services
Leonardo Vando, MD
Chief Executive Officer

Vantage Clinical Consulting LLC
Jamelia Hand, MHS, CADC, CODP
Chief Executive Officer

Vermonters for Criminal Justice Reform
Thomas Dalton, J.D., MA, LADC
Executive Director

VICTA
Lisa Peterson, LMHC, LCDP, LCDS, MAC
Chief Operating Officer

Individuals: Professionals

Michelle Accardi-Ravid, Ph.D., Clinical Psychologist, Acting Assistant Professor, University of Washington Medical Center/ Harborview Medical Center

Chris Alba, Harm Reduction Specialist, Health Innovations Inc

Onyinye Aleri, Case Manager, Charm City Care Connection

Sarah Baranes, MD Candidate

Anton Basenko, ME, Country Focal Point: PITCH, Alliance for Public Health

Donna Beers, MSN, RN-BC, CARN, Boston Medical Center

Leo Beletsky, J.D., MPH, Health in Justice Action Lab, Northeastern University Patricia Bellucci, Ph.D., Clinical Psychologist/Psychoanalyst

Daniel Bibeau, Ph.D., Professor of Public Health Education, University of North Carolina, Greensboro

F. Michler Bishop, Ph.D., Associate Professor, Director, Alcohol and Substance Abuse Services, Albert Ellis Institute, NY

Ricky N. Bluthenthal, Ph.D., Keck School of Medicine, University of Southern California

Elizabeth Bowen, PhD, Assistant Professor, University at Buffalo School of Social Work

Jennifer J. Carroll, Ph.D., MPH, Assistant Professor, Elon University

Sharon Chancellor, CSAC

Aaron Ferguson, The Social Exchange Podcast

Anna Fitz-James, MD, MPH

Kathleen Foley, PhD

Ryan Fowler, CRSW, Harm Reduction Program Coordinator, HIV/HCV Resource Center

Graeme Fox, Sonoran Prevention Works

David Frank, MMT Sociologist, Postdoctoral Research Fellow, New York University

Meryl Freedman, M.Ed, Families for Sensible Drug Policy

Ann Fuqua, BSN

Carmen Albizu Garcia, MD

Angie Geren, APP, CHt, Arizona Recovers

Louisa Gilbert, Co-Director, Social Intervention Group

Scott Goldberg, MD, Montefiore Medical Center

Judith R. Gordon, Ph.D., University of Washington

Traci Green, Ph.D., MSc, Opioid Policy Research Collaborative, the Heller School for Social Policy and Management, Brandeis University

Jennifer L Kimball, Berkshire Opioid Addiction Prevention Collaborative

Bethea Kleykamp, MA, Ph.D., Research Associate Professor, University of Rochester School of Medicine and Dentistry

Gary Langis, Harm Reduction Specialist, Boston Medical Center

Bethany Medley, MSW, Adjunct Lecturer, Columbia School of Social Work

Rosie Munoz-Lopez, MPH, Research Community Engagement Facilitator, Boston Medical Center

Janie L Kritzman, Ph.D., Lic. Psychologist, Psychological Associates, MA; NYSPA, Addiction Division

Dana Kurzer-Yashin, Overdose and Harm Reduction Trainer, Harm Reduction Coalition

David Lucas, MSW, Clinical Advisor, Center for Court Innovation

Samuel MacMaster, Ph.D., Associate Professor, Department of Family and Community Health, Baylor College of Medicine

Priya Mammen, MD, MPH, Physician, Kensington MMT Clinic

Marilena Marchetti, Co-Director, Liquid Handcuffs

Bayla Ostrach, MA, PhD

Steven Pacheco, Program Officer, Circle for Justice Innovations Fund

Ju Nyeong Park, Assistant Scientist, Johns Hopkins University

John P Pasagiannis, Ph.D., Clinical Psychologist

Stanton Peele, J.D., Ph.D., Founder, The Life Process Program

Bonnie A Peirano, MPH, Ph.D.

Sandra F Penn, MD, FAAFP

Kim Powers, Drug User Health Outreach Coordinator, AIDS Support Group Cape Cod

Garrett Reuscher, CASAC, MSW student, Social Intern, Footsteps

Helen Redmond, LCSW, Adjunct Faculty, Silver School of Social Work, New York University, and Co-Director of Liquid Handcuffs

Tina Reynolds, Program Director, Circle for Justice Innovations

Kathran Richardson, PRSS, Potomac Highlands Guild

Lindsay Roberts, MSW, NCSU Board Member and Sex Worker Liaison

Patrick Roff, Curriculum and Training Developer, Prevention is Key/CARES

Gabi Teed, BSW, CRSW, Perinatal SUD Care Coordinator, Amoskeag Health

Matthew Tice, LCSW, Pathways to Housing PA

Denise Tomasini-Joshi, J.D., MIA, Division Director, Open Society Foundations

Bruce G. Trigg, MD, Public Health and Addiction Medicine Consultant

Mary Kay Villaverde, M.S., Board Member, Families for Sensible Drug Policy

Ingrid Walker, Ph.D., Associate Professor, University of Washington, Tacoma

GracieLee Weaver, PhD, MPH, CHES, NBCHWC, University of North Carolina, Greensboro

Steffie Woolhandler, MD, MPH

Tyler Yates, CPSS, CADC-I, Syringe Exchange Program Coordinator, Guilford County Solution to the Opioid Problem

M. Scott Young, Research Associate Professor, University of South Florida

Jon E. Zibbell, PhD, Senior Scientist, RTI International / Emory University

Christie Chandler, MA, QP, North Carolina Harm Reduction Coalition

Hong Chen Chung, MD, MPH, Medical Consultant, Community Action Programs Inter-City, Inc

Seth Clark MD, MPH, Assistant Professor of Medicine and Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University

Kelley Cohill, LCSW-C

Susan E Collins, Ph.D., Co-Director, Harm Reduction Research and Treatment Center

Erica Darragh, Board Member, Students for Sensible Drug Policy; Chapter Director, DanceSafe

Jane Dicka, Health Promotion Team Coordinator, Harm Reduction

Victoria Mary Doneski, Program Manager, ONESTOP Harm Reduction Center

Patt Denning, PhD, Director of Clinical Services and Training, Harm Reduction Therapy Center

Cathy Dreifort, Harm Reduction Outreach Specialist, Shot in the Dark

Andria Efthimiou-Mordaunt MSc, Coordinator, John Mordaunt Trust

Nabila El-Bassel PhD, Director, Social Intervention Group

Taleed El-Sabawi, Assistant Professor, Elon University School of Law

Nancy Handmaker, Ph.D., Licensed Psychologist, Addictions Specialist

Jesse Harvey, CIPSS, RCA, Community Organizer, Church of Safe Injection

Jennifer I. Healy, Former Director, Bcbsma, Board Member, The Global Recovery Movement

Robert Heimer, PhD, Professor of Epidemiology, Yale School of Public Health

David Himmelstein, MD

Robert Hofmann, U.S. Movement Building Fellow, Students for Sensible Drug Policy

Heather Howard, Ph.D., Assistant Professor, Florida Atlantic University

Sheila Humphrey, Dayton Director, Harm Reduction Ohio

Lauren Jessell, MSW, Senior Research Associate

Sterling Johnson, Esq., Organizer, Black and Brown Workers Cooperative

Carol Jones, Director of Harm Reduction, Alliance for Living

Ashley Jordan, Adjunct Assistant Professor, City University of New York

Sharon Joslin, APRN, Director, Community Health Care Van, Yale University School of Medicine

Norty Kalishman, MD

Mary E. Kelly, PsyD, Psychologist

Stefan Kertesz, MD, Professor, University of Alabama

JoEllen Marsha, MPA, LEAD Program Director, CONNECT

Bethany Medley, MSW, Adjunct Lecturer, Columbia School of Social Work

Regina McCoy, MPH, MCHES, NBC-HWC, Professor, UNC Greensboro

Ryan McNeil, Ph.D., Assistant Professor & Director of Harm Reduction Research, Yale Program in Addiction Medicine, Yale School of Medicine

Nancy Mullin, MA, PsyD Graduate Student, California Institute of Integral Studies

Alicia Murray, DO, Addiction Psychiatrist, General Psychiatrist

Ethan Nadelmann, Founder and former Executive Director, Drug Policy Alliance

Daniel Nauts, MD, FASAM, Consultant/trainer, Montana Primary Care Association

Tammera V Nauts, LCSW, LAC, IBH Director, Montana Primary Care Association

Tracy R. Nichols, Ph.D., Department of Public Health Education, University of North Carolina, Greensboro

Danielle C. Ompad, Ph.D., Associate Professor, New York University School of Global Public Health

Caitlin O’Neill, Director of Harm Reduction Services, New Jersey Harm Reduction Coalition

Dinah Ortiz, NCSU Board Member

Lila Rosenbloom, MSW

Rene R Salazar, Ph.D., MPH, CIH, University of South Florida College of Public Health

Elizabeth A. Samuels, MD, MPH, mHS, Assistant Professor of Emergency Medicine, Brown Emergency Medicine

Vanessa Santana, Recovery Coach, Turning Point Recovery Center

Carolyn Sartor, Ph.D., Associate Professor, Yale School of Medicine

Roxanne Saucier, MPH

Jacob Schonberg, CPSS, Social Work Practitioner, UNC School of Medicine Mark Schulz, Associate Professor, University of North Carolina, Greensboro

Mandy Sladky RN, MSN, CARN, Opioid Project Manager and OBOT RN, Public Health Seattle & King County

Samuel Snodgrass, Ph.D., Board Member, Broken No More

Nicole Spector, RN, BSN, Health Innovations Inc

Annie Steinberg, President, GW Chapter Students for Sensible Drug Policy

Dr. Laura Stern, Sage Neuroscience Center

Janet K Stoltenborg, MS, MBA, Member, Moms for All Paths to Recovery from Addiction

Phillip Stracener, NCCPSS, BSW, Harm Reduction Specialist, AIDS Leadership Foothills-Area Alliance

Individuals: Allies

Sarah Beale
Jade Bower
Thomas Butler
Teri Cole-Smith
Elizabeth C. Day
Joseph Dishman
Nora Maria Fuller
Paul Gorman
Melvina Hall
Christie Hansen
Maggie Hart
Anna Herdlein
Emily Jones
Anna Kistin
Coleda Lee
Rivkah L. Meder
Whitney Meex
Bernadette Proctor
Rachel Rourke
Zach Salazar
Michael G. Seay
Kasey Snider
Zabrina Whiting


How to End Overdose: Building Overdose Prevention Programs that Truly Work

Words by Sarah Ziegenhorn

In the past five years, communities across Iowa have put together committees and task forces in order to identify solutions to the overdose crisis.

As a participant in multiple such committees, as well as a consultant providing technical assistance to State Targeted Opioid Response grant recipients (the grant through which the federal government has provided states with money to respond to the overdose crisis), I’ve played a role in developing plans to reduce overdose deaths. More importantly, I’ve also spent the past several years operating an overdose prevention and naloxone distribution program that serves the state of Iowa. Working in four cities and serving the counties surrounding these metro areas (as well as theoretically any Iowa county by mail), the program I direct has distributed nearing 40,000 doses of naloxone since July 1, 2017. Focusing our naloxone distribution on people who use drugs, our program has documented nearly 2,500 reports of overdose reversals. We suspect this number is higher in reality – these are just the individuals who have taken the time to come and tell us that they reversed an overdose with the naloxone we provided to them.

The results of our program are striking. And we believe that they have contributed to the significant decrease in overdose fatalities across the state. Yet, no city, county, or state agency has created a funding opportunity to support the critical life-saving work of our program. We’ve operated on a shoestring budget, selling t-shirts and utilizing volunteer labor, while the federal government has allocated millions of dollars to each state for the overdose crisis response. In the meantime, many community leaders, organizations, researchers, and elected officials have approached IHRC for assistance as they try to understand what strategies will work to end the overdose crisis and build programs based on the best available evidence. Because we routinely field questions from community members about how our program works, why we built it, and what sets of best practices, data, and evidence prop it up, I’ve put together an overdose prevention program starter pak. This set of resources provides some basic information about the history of naloxone access in the United States, and documents the ways in which harm reduction programs have found success in disseminating overdose prevention and response education while blanketing at-risk communities with free, accessible naloxone. This brief post is meant to summarize a few key resources that will help orient community leaders, advocates, elected officials, public health practitioners, researchers, health care providers, and others to the field of overdose prevention and provide a crash-course in what works.


A local paper, The Gazette, reviews comparative findings of one year’s worth of naloxone distribution from community-based organizations and naloxone administrations performed by law enforcement departments. The editorial echos the findings of many of the research studies summarized below: while law enforcement naloxone access can be positive, prioritizing naloxone access for people who use drugs is the most important strategy for making a dent in overdose deaths.

Know Your History: The Origins of Naloxone Distribution

In late 2019, Eliza Wheeler posted an article to Medium, written in celebration of a distribution of 1,000,000 doses of naloxone by harm reduction programs in 2019 and in memory of her late friend and colleague, Dan Bigg. Bigg founded the Chicago Recovery Alliance in the early 1990s and is the driving force around the availability of naloxone outside of hospitals today. While it is now customary for law enforcement officers, EMS, firefighters, and the like to carry naloxone, this is a major departure from the 1990s, when naloxone was a little-known drug relegated to surgical suites and the practices of anesthesiologists. Bigg was a visionary who worked to deregulate this silver bullet and promoted mass distribution of naloxone at the community level. He fundamentally believed that the best people to possess and administer naloxone were people who use drugs themselves, and his theory has proved accurate. Wheeler, who administers a buyers club for harm reduction programs looking to purchase naloxone, has researched naloxone administration in community settings (see below) and found that people who use drugs (as a group) administer far, far, far more naloxone than any other group of professionals charged with protecting the health and safety of the public.

Just this month, Nancy D. Campbell released a long-awaited new book on the history of the U.S. opioid crisis, naloxone, and the harm reduction community’s organized response. Campbell, a social scientist, has followed up a series of excellent books on drug policy with what is essentially a history of the harm reduction community’s work to create programs and services informed and operated by the experiences of people who use drugs. OD: Naloxone and the Politics of Overdose, “charts the emergence of naloxone as a technological fix for overdose and describes the remaking of overdose into an experience recognized as common, predictable, patterned―and, above all, preventable. Naloxone, which made resuscitation, rescue, and “reversal” after an overdose possible, became a tool for shifting law, policy, clinical medicine, and science toward harm reduction. Liberated from emergency room protocols and distributed in take-home kits to non-medical professionals, it also became a tool of empowerment. After recounting the prehistory of naloxone―the early treatment of OD as a problem of poisoning, the development of nalorphine (naloxone’s predecessor), the idea of “reanimatology”―Campbell describes how naloxone emerged as a tool of harm reduction.”

Putting it Together: Best Practice Guidelines

A number of governmental and non-governmental organizations have created summary documents of the research that has emerged from the programs that Bigg designed and that operate along similar principles. Many studies have evaluated whether the prioritization of naloxone distribution directly to people who use drugs is truly effective at reducing overdose deaths at a community level. Several key summary documents have emerged in past years.

A 2018 report from the CDC reviews a set of evidence-based strategies for reducing overdose deaths. The report is designed as an instruction manual of sorts, meant to assist individuals working at the community-level with development of programs and policies. It reviews a set of programs to which there is a corresponding evidence-base, highlighting those programs and policies which are deemed to be most effective.

In 2019, the research organization RTI brought together a group of experts with experience operating overdose prevention and naloxone distribution programs, or working in the broader overdose prevention field in another capacity. The intent: to create a document with guidelines that would help stakeholders understand what policies and principles are needed to operate a successful program that achieves its stated goals. {Full disclosure, I was one of the key informants or “experts” interviewed for this project.} The result is an excellent summary of the approaches used within strong and effective overdose prevention programs. Many organizations have attempted naloxone distribution in past years, with a wide range of stakeholder organizations working to improve access. Yet, experts in the report identify a number of programmatic requirements that can halt a program from being effective and essentially serve as barriers.

The inimitable national Harm Reduction Coalition designed a stepwise guide that is useful reading for those with the goal of eliminating overdose. This manual is designed to outline the process of developing and managing an Overdose Prevention and Education Program, with or without a take-home naloxone component. Overdose prevention work can be easily integrated into existing services and programs that work with people who use or are impacted by drugs, including shelter and supportive housing agencies, substance abuse treatment programs, parent and student groups, and by groups of people who use drugs outside of a program setting.

Harm Reduction Coalition: Overdose Prevention & Naloxone Manual

Bonus

Overdose prevention programs are at their most effective when they put naloxone directly into the hands of those who are most at risk of overdose: individuals who use heroin and illicit drugs that may be unknowingly contaminated with synthetic opioids (eg. fentanyl). The general goal of these programs is to blanket a community of drug users with naloxone. There is theoretically one distribution network that is most likely to permeate this network of individuals: people who sell illicit drugs. Reporting from Filter explores the ways in which public health programs can take advantage of these markets and distribution channels to ensure all individuals at-risk are armed with the overdose reversal agent.


An Important Statement from the Iowa Harm Reduction Coalition regarding the Cedar Rapids Police Chief

As the 2020 legislative session begins, IHRC staff have been made aware by multiple legislators that we have been the subject of slander and misinformation at the hands of the Cedar Rapids Chief of Police, Wayne Jerman.

Specifically, multiple legislators have reported that Chief Jerman claims IHRC distributes “crack pipes” and “tells community members not to call 911 in the event of an overdose.” As a result of these lies, legislators now say they are disinclined to support bills legalizing syringe service programs in Iowa, and that this withdrawal of support involves lawmakers who were previously very supportive of this evidence based legislation in particular, and of the work of IHRC in general.

This news is deeply troubling to our organization, as both claims are unequivocally false. IHRC neither distributes crack pipes nor do we encourage individuals not to call 911. These statements are slanderous and harmful. Moreover, we are shocked and disappointed that an official charged with the public trust would fabricate information in order to sway the opinion of elected officials away from support of legislation that would serve only to save lives and prevent the spread of devastating and costly infections. In his role as the Cedar Rapids Police Chief and the Legislative Chair and Liaison of the Iowa Police Chiefs Association, Chief Jerman has been a vocal opponent of these programs and their legalization, despite the robust success of syringe service programs in nearly 40 states across the country. A policy disagreement, however misinformed, is an expected part of legislative advocacy. Spreading lies in the hopes of gaining political advantage is not.

Addressing the particular claims: First, we do not distribute pipes. Period. Full stop. While harm reduction programs work to reduce the transmission of infectious disease, there is relatively little evidence to suggest that infectious disease transmission is facilitated through the sharing of pipes. There is no language in the current syringe service program bill that would legalize the distribution of pipes through public health programs. There is zero evidence to suggest that our programs distribute pipes and anyone with even a cursory familiarity with our work would understand how ridiculous this allegation is.

For those who are curious about what services we do provide, we welcome individuals to contact us at hello@iowaharmreductioncoalition.org to arrange a tour of our offices. You may also visit our website, where we keep a complete description of the services we do provide: https://www.iowaharmreductioncoalition.org/services/

Second, IHRC is an organization led, in part, by physicians and physicians in training. As such, we strongly believe in working with community members to ensure that they receive medical care when necessary and when their consent is given. We take the hippocratic oath (to do no harm) seriously and work to provide services that are deeply ethical and in line with our sworn oath. We have never instructed community members not to call 911 in the event of an overdose. On the contrary, we instruct our clients to seek medical care following an overdose and educate them on the importance of receiving follow-up care. These written instructions, included in every overdose reversal kit we distribute, are available on our website as well: https://www.iowaharmreductioncoalition.org/overdose-education-naloxone-distribution/

Our commitment to health care partnership and navigation can be demonstrated in many components of our programming. This includes robust programming to link people into both healthcare and addiction treatment. Through our programs, we bring hundreds of individuals annually into emergency departments and clinical appointments. Our staff accompanies clients to begin medication assisted treatment, receive care for skin and soft tissue infections, enter the hospital for suicidal ideation or severe mental illness, and initiate treatment for hepatitis C, HIV, and more.

“IHRC is very disappointed to hear that a campaign of misinformation is being led by someone who has sworn to protect and serve our community,” said Dr. Joshua Radke, IHRC Medical Director. “As an evidence driven organization, we take seriously promoting efforts which serve our mission – to promote the health, safety, and dignity of our participants. The claims that were made do not align with this mission, and are therefore not part of our work. As IHRC’s Medical Director and as an emergency department physician, I am especially appalled by any allegation that we do not promote emergency medical response. IHRC will continue to promote science-based programs and policy and will offer services that align with our organization’s core goals and values.”

These lies harm our community members and undermine the trust elected officials place in physicians, public health experts, and researchers. In order to ensure that elected officials receive the best available information regarding science, medicine, and public health, it is critical that law enforcement leadership refrain from making baseless allegations and stick to the facts. While we do not expect everyone to appreciate the legislation to authorize needle exchange programs in Iowa, we do expect that discussions about it will be professional, ethical, and mature, while maintaining a spirit of cooperation and collegiality. We also wish to stress that we enjoy positive working relationships with many law enforcement officers around the state and nation and are deeply grateful for the service these individuals perform in our community. This statement should not be taken as a criticism of this professional community, but of the single actions of one bad actor.

We remain committed to advancing this legislation as we believe that all Iowans deserve to live a life free of HIV, liver failure (the impact of hepatitis C), and devastating infections of the blood and heart, all of which are easily preventable through syringe service programs. When it comes to the human impacts of syringe exchange, there is no debate: these programs save lives. We trust that community members and elected officials will continue to recognize this indisputable fact and choose to ignore this ill-informed and weak anti-Iowan propaganda.


Tulsi Gabbard

Tulsi Gabbard on Criminal Justice Reform

Gabbard pledges she would end the war on drugs.

Gabbard pledges to end cash bail.

Gabbard introduced the Ending Federal Marijuana Prohibition Act of 2019, which would limit the application of Federal laws to the distribution and consumption of marijuana and would remove marijuana from the list of Schedule l substances under the Controlled Substances Act.

Gabbard would remove marijuana-related convictions from “otherwise law-abiding Americans.”

Gabbard received increased national attention after criticizing Senator Kamala Harris for her record as former Attorney General for California stating, “... and the people who suffered under your reign as California prosecutor -- you owe them an apology.”

Gabbard would pass the End Money Bail Act, and would provide resources to states to implement a free trial, no money bail system.

Gabbard has pledged to provide resources to states to reduce the jail population, ensure safer communities, and save taxpayer dollars.

Gabbard promises to shut down the school-to-prison pipeline.

Gabbard pledges she will work for clemency reform, including expunging the criminal records of individuals convicted of non-violent drug offenses.

Gabbard says she will work to make house arrest and work release “more viable for non-violent offenders” with the aim to prevent jail and prison entry.

Gabbard would legalize marijuana at the federal level.

Gabbard would ban private prisons.

Gabbard cosponsored the Marijuana Justice Act of 2019, which would economically punish states that do not legalize cannabis and continue to incarcerate or arrest people for cannabis-related offenses.

Gabbard is a cosponsor of the FIRST STEP Act, which aims to reduce the prison population by strengthening evidence-based, rehabilitative programs for those who are incarcerated.

When asked by an audience member at a 2019 CNN Town Hall event if Gabbard would decriminalize all drugs, Gabbard responded by saying that after with meeting with a group of men living in a substance use recovery facility in New Hampshire, she was “impressed by their strength and their resilience,” that we need to end the failed war on drugs, that she feels it is important to identify the root causes of addiction, and discussed her introduction of the Ending the Federal Marijuana Prohibition Act of 2019. CNN host ____ then asked for further detail saying, “So Congresswoman, you’re talking a lot about marijuana, but where do you draw the line on decriminalization, because one of the questions was about all drugs. What do you think about that?” Gabbard replied, “I think that the heart of her question was really recognizing that this is about addiction, not criminalization. Our failed war on drugs has turned everyday Americans who are struggling with substance abuse and addiction and turned them into criminals.” Gabbard did not provide an answer regarding the legalization of all substances.

Gabbard would abolish mandatory minimum sentences for non-violent drug offenses.

Gabbard promises to provide expanded education opportunities, vocational training, and mental health services for individuals in prison.

Gabbard promises to never sign another mandatory minimum sentence into law that removes discretion from judges.

“Our outdated policies on marijuana are turning everyday Americans into criminals, tearing apart families, and wasting huge amounts of taxpayer dollars to arrest, prosecute, and incarcerate people for non-violent marijuana charges.”

“We must stand up against for-profit, private prisons and a criminal justice system that favors the rich and powerful and punishes the poor, locking up people who smoke marijuana and ignoring corps like Purdue Pharma responsible for thousands of opioid-related deaths.”

“…too often we have people in positions of power who don’t care about serving the people. They don’t care about actually serving justice. Instead, they are using their position of power and privilege for their own selfish interests. It’s unfortunately because so much a part of the fabric of our society, that we barely bat an eye when Wall Street bankers who have cheated and gambled and lost billions of our money have not served a day in prison, and they are actually rewarded with million-dollar bonuses. We have big pharmaceutical companies, companies like Purdue Pharma, who have cheated and lied to the American people just so they can proliferate these highly addictive opioid drugs on our streets, driving up their profits, ruining people’s lives, causing the deaths of tens of thousands of people. Yet, what happens to them? They walk away. They get a slap on the wrist. Meanwhile, on the other hand, we have nonviolent drug offenders arrested, thrown in prison, shackled with a criminal record that will follow them wherever they go forever. These are just two examples of this fundamentally unjust system that we have. We have mass incarceration that’s predominantly impacted poor people and communities of color, people’s lives ruined because of one mistake while others whose entire careers are built on predatory behavior and exploitation of the innocent are routinely excused. This is not justice. Justice must be blind… Anyone who’s come into contact with our prison system in any way knows that it is deeply broken. Not only does our prison system fail to fulfill its function of deterring and correcting crime, it is a central driver of a conveyor belt that sucks our youth into an ever-increasing spiral of offenses, punishment, and collateral consequences.”

Learn more about this issueRead the positions and proposals of this candidate for other issues

Tulsi Gabbard on Overdose Prevention Sites

When asked by a radio listener during an interview how Gabbard feels about “needle exchange programs and these safe spaces for people who if they have an addiction to drugs and whatnot,” Gabbard expressed support. It is unclear whether the radio listener was referring to safe consumption spaces in her question, or as to whether Gabbard’s answer of support was meant to include safe consumption spaces.

When asked by a listener in a radio interview with New Hampshire Public Radio how Gabbard felt about needle exchange programs and safe consumption spaces, Gabbard answered, “I think that these programs, and I’ve heard a lot about kind of the Hub and Spoke program here in New Hampshire that are being implemented at the local level, do so much towards helping people find that safe space to begin that tough path towards recovery, towards ending that addiction. I want to bring up one thing that I think the state legislature here [New Hampshire] has passed, I think through the House [of Representatives], and that that is marijuana. I’ve introduced legislation at the federal level to end the federal marijuana prohibition for a whole host of reasons, but one of which is how we’ve seen a direct correlation in states that have either passed medical marijuana or completely decriminalized marijuana. We’ve seen that correlation in a drop in opioid addiction and also a correlating drop in opioid related deaths. So I think there’s a number of different avenues that we need to pursue to address this opioid crisis. Not a single one of them alone will be effective in doing so, but we have to treat it like the crisis that it is both in accountability and prosecution for those responsible for proliferating these drugs, and recovery and treatment and help for those who are suffering at the brunt of this crisis.” NHPR host Peter Biello followed up by asking for a clear yes or no on whether needle exchanges are a “good idea.” Gabbard responded, “Yes.”

Read More

2020 Candidate Conversation: U.S. Rep. Tulsi Gabbard
March 21, 2019 | New Hampshire Public Radio

Read the positions and proposals of this candidate for other issuesLearn more about this issue

Tulsi Gabbard on HIV Getting to Zero

Gabbard has not yet completed a survey about HIV policy issued by AIDS United, nor issued specific statements to this issue.

Read the positions and proposals of this candidate for other issuesLearn more about this issue

Tulsi Gabbard on Hepatitis C Treatment Access

Gabbard has not issued specific statements to this issue.

In 2016, while serving as a House Representative for Hawai’i, Gabbard voted in favor of the Military Construction and Veteran Affairs funding bill for Fiscal Year 2017, which included $850 million for health care needs of veterans, including treatment of hepatitis C.

Read the positions and proposals of this candidate for other issuesLearn more about this issue

Tulsi Gabbard on Voting Rights Restoration

A spokeswoman for Gabbard stated that felons should not be able to vote while under the control of law enforcement, including while on parole, because their votes could be “unduly influenced by those authorities.”

Gabbard has not personally issues specific statements to this issue.

Read More

2020 Candidates Are Very Hesitant About Letting Prisoners Vote
Sam Levine and Igo Bobic, April 10, 2019 | HuffPost

Read the positions and proposals of this candidate for other issuesLearn more about this issue

Tulsi Gabbard on Drug Decriminalization

Gabbard introduced the Ending Federal Marijuana Prohibition Act of 2019, which would limit the application of Federal laws to the distribution and consumption of marijuana and would remove marijuana from the list of Schedule l substances under the Controlled Substances Act.

Gabbard cosponsored the VA Medical Cannabis Research Act of 2019 to direct the Secretary of Veteran Affairs to carry out a clinical trial of the effects of cannabis on certain health outcomes of adults with chronic pain and post-traumatic stress disorder.

Gabbard co-introduced the Opioid Crisis Accountability Act of 2019, which would prohibit the illegal marketing and distribution of opioids, would create criminal liability for top company executives, would penalize drug manufacturers who illegally advertise, market, or distribute an opioid product, and would require drug makers to reimburse the country for the negative economic impact of their drugs.

Gabbard cosponsored the Marijuana Justice Act of 2019, which would economically punish states that do not legalize cannabis and continue to incarcerate or arrest people for cannabis-related offenses.

Gabbard would remove marijuana-related convictions from “otherwise law-abiding Americans.”

In 2017, Gabbard signed onto a letter to Eric Hargan, Acting Secretary at the time for the U.S. Department of Health and Human Services urging the department to allow research of medical marijuana as a pain management alternative to opioids.

When asked by an audience member at a 2019 CNN Town Hall event if Gabbard would decriminalize all drugs, Gabbard responded by saying that after with meeting with a group of men living in a substance use recovery facility in New Hampshire, she was “impressed by their strength and their resilience,” that we need to end the failed war on drugs, that she feels it is important to identify the root causes of addiction, and discussed her introduction of the Ending the Federal Marijuana Prohibition Act of 2019. CNN host ____ then asked for further detail saying, “So Congresswoman, you’re talking a lot about marijuana, but where do you draw the line on decriminalization, because one of the questions was about all drugs. What do you think about that?” Gabbard replied, “I think that the heart of her question was really recognizing that this is about addiction, not criminalization. Our failed war on drugs has turned everyday Americans who are struggling with substance abuse and addiction and turned them into criminals.” Gabbard did not provide an answer regarding the legalization of all substances.

“As the opioid epidemic continues to ravage communities across the country, we must pursue every available path to prevent, treat, and ultimately end America’s reliance on these highly addictive drugs… With the Ending Federal Marijuana Prohibition Act, we can begin to rectify decades of misguided law enforcement policy and focus on solutions. We can work for people like veterans and healthcare advocates instead of pharmaceutical lobbyists who will continue to push dangerous and addictive painkillers even amidst an opioid epidemic. Ending Federal Marijuana Prohibition is the best way forward for our criminal justice and healthcare systems.”

“We must end this failed war on drugs. I introduced bipartisan legislation that would end the federal prohibition on marijuana. This will have a great impact on the opioid crisis. In states where marijuana is legalized, we have seen a drop in opioid addiction, and a drop in opioid-related deaths. This will have an impact on our economy in so many different ways, as well as taking a huge bite out of our broken criminal justice system, where far too many nonviolent drug offenders are wasting away.”

“The fact that marijuana’s still a Schedule I drug is unacceptable in the harm that it is causing to the people of our country and to taxpayers as well. The impact this has on individuals, potentially leading to criminal records that impact them, their families, their ability to get a job, housing, financial aid for college–the impacts of this are great. That’s not to speak of the impact on states, small businesses and banks in those states that have legalized some level of marijuana.”

“I believe firmly in every person’s freedom to make their own choices, and that people should not be thrown in jail and incarcerated or made into criminals for choosing to smoke marijuana whether it be for medicinal and non-medicinal purposes.”

Read More

Read the positions and proposals of this candidate for other issuesLearn more about this issue

Tulsi Gabbard on Substance Use Treatment Access

Gabbard voted to pass the Comprehensive Addiction and Recovery Act (CARA) of 2016, which requires the Department of Health & Human Services to provide grants to states for substance use treatment and expanded.

Gabbard supports Medicare for All.

When asked in by Ronald Haley, member of the 2020 Bipartisan Justice Center whether she would commit to freeing individuals who are incarcerated due to drug charges, Gabbard responded, “Yes… we have to completely change the way that we are viewing this challenge where people are being and have been incarcerated purely for drug use violations while many others are going scot free. Being incarcerated because they are victims of this failed war on drugs that’s been waged now for decades that really has not solved any of the problems that they said it would solve, but really has just proven to be so costly for the people who have been caught up in that net. Drug abuse, substance abuse, and addiction requires health care and health treatment. Often there are other issues that surround drug use and addiction – issues related to mental health or other things where people are self-medicating rather than actually being able to get the help that they need. This issue, like so many others, if we actually get to the root cause of the problems that’s causing this action or reaction to occur, and provide that service, provide that help, then we can prevent so much of the pain and the suffering that occurs as a result.”

“This is about recovery. This is about addiction. We need to address that reality and help resolve some of the root causes of why people are turning to different substances in the first place… Our failed war on drugs has turned everyday Americans who are struggling with substance abuse and addiction and turned them into criminals.”

While discussing opioids, Gabbard said, “We’ve got to look at treatment, and actually providing resources towards recovery and making it so that we are not treating addiction as a crime but rather as something that, we need to be able to provide people with help in putting their lives back together and walking that path forward.”

Read the positions and proposals of this candidate for other issuesLearn more about this issue

Tulsi Gabbard on Syringe Access

Gabbard has expressed support for needle exchange programs as a “good idea.”

When asked by a listener in a radio interview with New Hampshire Public Radio how Gabbard felt about needle exchange programs and safe consumption spaces, Gabbard answered, “I think that these programs, and I’ve heard a lot about kind of the Hub and Spoke program here in New Hampshire that are being implemented at the local level, do so much towards helping people find that safe space to begin that tough path towards recovery, towards ending that addiction. I want to bring up one thing that I think the state legislature here [New Hampshire] has passed, I think through the House [of Representatives], and that that is marijuana. I’ve introduced legislation at the federal level to end the federal marijuana prohibition for a whole host of reasons, but one of which is how we’ve seen a direct correlation in states that have either passed medical marijuana or completely decriminalized marijuana. We’ve seen that correlation in a drop in opioid addiction and also a correlating drop in opioid related deaths. So I think there’s a number of different avenues that we need to pursue to address this opioid crisis. Not a single one of them alone will be effective in doing so, but we have to treat it like the crisis that it is both in accountability and prosecution for those responsible for proliferating these drugs, and recovery and treatment and help for those who are suffering at the brunt of this crisis.” NHPR host Peter Biello followed up by asking for a clear yes or no on whether needle exchanges are a “good idea.” Gabbard responded, “Yes.”

Read More

2020 Candidate Conversation: U.S. Rep. Tulsi Gabbard
March 21, 2019 | New Hampshire Public Radio

Read the positions and proposals of this candidate for other issuesLearn more about this issue

Get Involved

Find out more about IHRC's advocacy efforts.

Learn More

Become an IHRC volunteer.

Apply Now

Register for IHRC's 2020 Day on the Hill.

Learn More

Learn how to throw your very own IHRC advocacy party.

Learn More

Sign up to join IHRC's general email list.

Sign Up